Newsroom
Featured News
Image
Patient Voices
For David and his mother, Melissa, moments of joy are an important part of life with Alexander disease (AxD), an ultra-rare, progressive and often fatal neurological disorder that affects approximately 1 in 1 to 3 million people worldwide.
People & Impact
Beth’s recognition reflects more than 25 years of leadership at Ionis. As a member of the executive leadership team, she has helped guide the company’s transformation from an organization focused primarily on research and early development into a fully integrated commercial-stage biotech.
Image
Patient Voices
When triglyceride levels reach 500 mg/dL or higher, the risks of serious complications like acute pancreatitis and atherosclerotic cardiovascular disease can increase. Watch as people living with sHTG share their experiences and reveal the often-misunderstood realities of living with this serious condition.
Image
Innovation at Work
Advances in science and treatment are changing how severe hypertriglyceridemia (sHTG) is identified and managed. Here are four trends helping shape the future of care.
Image
Recent posts
Image
Patient Voices
Finding Joy in the Journey: David and Melissa’s Life with Alexander disease (AxD)
Image
People & Impact
Ionis’ CFO Beth Hougen Named 2026 CFO of the Year by San Diego Business Journal
Image
Image
Innovation at Work
Four Trends That Will Shape the Future of Severe Hypertriglyceridemia (sHTG) Management
Image
People & Impact
Ionis recognized as a Top 3 Best Place to Work by San Diego Business Journal
Image
Patient Voices
Living with an Invisible Illness: Yajaira’s Journey with Severe Hypertriglyceridemia (sHTG)
Image
People & Impact
Our 2025 Corporate Responsibility Report: Building Momentum for Better Futures
Image
Patient Voices
From Treating ATTR-CM to Living with It: A Conversation with a Cardiologist
Image
Defining Moments
Ionis JPM 2026 Takeaways: Breakthrough Therapies Driving Accelerating Growth
Sign up for investor news alerts
For the latest on Ionis investor news.